Subarachnoid haemorrhage

R Al-Shahi, PM White, RJ Davenport, KW Lindsay - Bmj, 2006 - bmj.com
Patients with spontaneous (non-traumatic) subarachnoid haemorrhage usually present first
to their general practitioner. As general practitioners may see only a few cases during their …

[HTML][HTML] Early treatment with prednisolone or acyclovir in Bell's palsy

FM Sullivan, IRC Swan, PT Donnan… - … England Journal of …, 2007 - Mass Medical Soc
Background Corticosteroids and antiviral agents are widely used to treat the early stages of
idiopathic facial paralysis (ie, Bell's palsy), but their effectiveness is uncertain. Methods We …

[HTML][HTML] National survey of UK medical students on the perception of neurology

J Pakpoor, AE Handel, G Disanto, RJ Davenport… - BMC medical …, 2014 - Springer
Background Medical students perceive neurology to be a difficult subject, a phenomenon
described as “neurophobia”. Studies investigating student attitudes towards neurology have …

How to do it: investigate exertional rhabdomyolysis (or not)

PM Fernandes, RJ Davenport - Practical Neurology, 2019 - pn.bmj.com
Rhabdomyolysis is the combination of symptoms (myalgia, weakness and muscle swelling)
and a substantial rise in serum creatine kinase (CK)> 50 000 IU/L; there are many causes …

Alpha4-integrin antagonism—an effective approach for the treatment of inflammatory diseases?

RJ Davenport, JR Munday - Drug discovery today, 2007 - Elsevier
Inhibition of leucocyte trafficking by antagonism of the alpha4 (α4)-integrin has now been
validated as a therapeutic approach for the treatment of inflammatory diseases such as …

Effect of correcting outcome data for case mix: an example from stroke medicine

RJ Davenport, MS Dennis, CP Warlow - Bmj, 1996 - bmj.com
Objective: To show the influence of variations in case mix on clinical outcome indicators for
patients admitted to hospital with acute stroke. Design:“Before and after” cohort study, with …

Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors

M Alam, RE Beevers, T Ceska, RJ Davenport… - Bioorganic & medicinal …, 2007 - Elsevier
Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors -
ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & Books Search …

A novel series of potent and selective IKK2 inhibitors

AH Bingham, RJ Davenport, L Gowers… - Bioorganic & Medicinal …, 2004 - Elsevier
A novel series of aminopyrimidine IKK2 inhibitors have been developed which show
excellent in vitro inhibition of this enzyme and good selectivity over the IKK1 isoform. The …

Synthesis of novel substituted isoquinolones

N Briet, MH Brookes, RJ Davenport, FCA Galvin… - Tetrahedron, 2002 - Elsevier
Synthesis of novel substituted isoquinolones - ScienceDirect Skip to main contentSkip to
article Elsevier logo Journals & Books Search RegisterSign in View PDF Download full issue …

Synthesis and structure–activity relationships of guanine analogues as phosphodiesterase 7 (PDE7) inhibitors

MJ Barnes, N Cooper, RJ Davenport, HJ Dyke… - Bioorganic & medicinal …, 2001 - Elsevier
Synthesis and structure–activity relationships of guanine analogues as phosphodiesterase 7
(PDE7) inhibitors - ScienceDirect Skip to main contentSkip to article Elsevier logo Journals & …